Faithlore P. Gardner

Hematology | Oncology
1708 Cape Coral Pkwy W Ste 10
Cape Coral, FL 33914

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 7 publications

Phase 3 PERSPECTIVE study: Ibrutinib with rituximab for initial treatment of patients with follicular lymphoma.

Phase 3 PERSPECTIVE study: Ibrutinib with rituximab for initial treatment of patients with follicular lymphoma.

Journal: HemaSphere
Published: September 17, 2025

Phase II trial of enfortumab vedotin in patients with previously treated gastric and esophageal cancers.

Phase II trial of enfortumab vedotin in patients with previously treated gastric and esophageal cancers.

Journal: ESMO open
Published: March 31, 2025

Analysis of peripheral neuropathy in the POLARIX study using clinician- and patient-reported outcomes.

Analysis of peripheral neuropathy in the POLARIX study using clinician- and patient-reported outcomes.

Journal: Blood advances
Published: September 03, 2024

Results of a Randomized, Double-Blind, Placebo-Controlled, Phase 1b/2 Trial of Nabpaclitaxel + Gemcitabine ± Olaratumab in Treatment-Naïve Participants with Metastatic Pancreatic Cancer.

Results of a Randomized, Double-Blind, Placebo-Controlled, Phase 1b/2 Trial of Nabpaclitaxel + Gemcitabine ± Olaratumab in Treatment-Naïve Participants with Metastatic Pancreatic Cancer.

Journal: Cancers
Published: January 10, 2024

Margetuximab with retifanlimab as first-line therapy in HER2+/PD-L1+ unresectable or metastatic gastroesophageal adenocarcinoma: MAHOGANY cohort A.

Margetuximab with retifanlimab as first-line therapy in HER2+/PD-L1+ unresectable or metastatic gastroesophageal adenocarcinoma: MAHOGANY cohort A.

Journal: ESMO open
Published: June 08, 2022

c-MET expression in primary and liver metastases in uveal melanoma.

c-MET expression in primary and liver metastases in uveal melanoma.

Journal: Melanoma research
Published: September 12, 2014

Clinical reasoning: a 69-year-old man with leukocytosis and hemorrhagic brain lesions.

Clinical reasoning: a 69-year-old man with leukocytosis and hemorrhagic brain lesions.

Journal: Neurology
Published: July 02, 2014
Showing 1-7 of 7

Last Updated: 09/26/2026